ArticleInternational ophthalmology2018
Intravitreal anti-VEGF treatment for subretinal neovascularisation secondary to type 2 idiopathic juxtafoveolar telangiectasia.
Teresa Barth et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it